174 related articles for article (PubMed ID: 6209043)
41. Ia-like (HLA-DR) antigens in the diagnosis of lymphoma and undifferentiated tumors.
Kadin ME
Arch Pathol Lab Med; 1980 Oct; 104(10):503-508. PubMed ID: 6998408
[TBL] [Abstract][Full Text] [Related]
42. Some fixation reagents reduce or abolish the detectability of Ia-antigen and HLA-DR on cells.
Walker WS; Beelen RH; Buckley PJ; Melvin SL; Yen SE
J Immunol Methods; 1984 Feb; 67(1):89-99. PubMed ID: 6421936
[TBL] [Abstract][Full Text] [Related]
43. Presence of HLA-D/DR antigens on the membrane of breast tumour cells.
Bernard D; Maurizis JC; Rusé F; Chassagne J; Chollet P; Sauvezie B; de Latour M; Plagne R
Clin Exp Immunol; 1984 Apr; 56(1):215-21. PubMed ID: 6370519
[TBL] [Abstract][Full Text] [Related]
44. Discordant expression of human Ia-like antigens on hematopoietic progenitor cells.
Linch DC; Nadler LM; Luther EA; Lipton JM
J Immunol; 1984 May; 132(5):2324-9. PubMed ID: 6609195
[TBL] [Abstract][Full Text] [Related]
45. A combined immunohistological and histochemical analysis of lymphocyte and macrophage subpopulations in the rheumatoid nodule.
Duke OL; Hobbs S; Panayi GS; Poulter LW; Rasker JJ; Janossy G
Clin Exp Immunol; 1984 May; 56(2):239-46. PubMed ID: 6375915
[TBL] [Abstract][Full Text] [Related]
46. IA antigens and antigen-presenting function of thymic macrophages.
Beller DI; Unanue ER
J Immunol; 1980 Mar; 124(3):1433-40. PubMed ID: 7358986
[TBL] [Abstract][Full Text] [Related]
47. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
48. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens.
Biddison WE; Shaw S
Diagn Immunol; 1983; 1(3):112-5. PubMed ID: 6209053
[TBL] [Abstract][Full Text] [Related]
49. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
Falkenburg JH; van der Vaart-Duinkerken N; Veenhof WF; Goselink HM; van Eeden G; Parlevliet J; Jansen J
Exp Hematol; 1984 Dec; 12(11):817-21. PubMed ID: 6210206
[TBL] [Abstract][Full Text] [Related]
50. The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes.
Newman RA; Ormerod MG; Greaves MF
Clin Exp Immunol; 1980 Sep; 41(3):478-86. PubMed ID: 7002399
[TBL] [Abstract][Full Text] [Related]
51. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.
Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I
Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461
[TBL] [Abstract][Full Text] [Related]
52. Characterization of accessory cells required for helper T cell induction in vitro: evidence for a phagocytic, Fc-receptor, and Ia-bearing cell type.
Erb P; Stern AC; Alkan SS; Studer S; Zoumbou E; Gisler RH
J Immunol; 1980 Dec; 125(6):2504-7. PubMed ID: 6968786
[TBL] [Abstract][Full Text] [Related]
53. The involvement of interdigitating (antigen-presenting) cells in the pathogenesis of rheumatoid arthritis.
Poulter LW; Duke O; Hobbs S; Janossy G; Panayi G; Seymour G
Clin Exp Immunol; 1983 Feb; 51(2):247-54. PubMed ID: 6220847
[TBL] [Abstract][Full Text] [Related]
54. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
[TBL] [Abstract][Full Text] [Related]
55. Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.
Kallenberg CG; Schilizzi BM; Beaumont F; Poppema S; De Leij L; The TH
Clin Exp Immunol; 1987 Jan; 67(1):182-90. PubMed ID: 3621672
[TBL] [Abstract][Full Text] [Related]
56. Chemotactic macrophage subpopulations defined by macrophage chemotactic factors from delayed hypersensitivity reaction sites.
Honda M; Yoshimura T; Watanabe T; Hayashi H
J Immunol; 1983 Dec; 131(6):2989-94. PubMed ID: 6196408
[TBL] [Abstract][Full Text] [Related]
57. The role of products of the human HLA-DR locus (Ia molecules) in in vitro M. leprae driven lymphoproliferation.
Haregewoin A; Yemaneberhan T; Belehu A
Clin Exp Immunol; 1983 Aug; 53(2):328-34. PubMed ID: 6349878
[TBL] [Abstract][Full Text] [Related]
58. Inhibitory activity of antibodies to human Ia-like determinants: comparison of intact and pepsin-digested antibodies.
Muchmore AV; Megson M; Decker JM; Knudsen P; Mann DL; Broder S
J Immunol; 1983 Aug; 131(2):725-30. PubMed ID: 6408187
[TBL] [Abstract][Full Text] [Related]
59. Expression of Ia by murine alveolar macrophages is upregulated during the evolution of a specific immune response in pulmonary parenchyma.
Kaltreider HB; Byrd PK; Curtis JL
Am Rev Respir Dis; 1988 Jun; 137(6):1411-6. PubMed ID: 2462375
[TBL] [Abstract][Full Text] [Related]
60. Discrepancy in expression ability of Tac antigen and Ia determinants defined by monoclonal antibodies on activated or cultured cord blood T lymphocytes.
Yokoi T; Miyawaki T; Yachie A; Ohzeki S; Taniguchi N
J Immunol; 1982 Oct; 129(4):1441-5. PubMed ID: 6980936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
